TRNS

Transcat Inc
NASDAQINDUSTRIALSSPECIALTY BUSINESS SERVICES

Key Statistics

Market Cap
$821.14M
P/E Ratio
243.69
EPS
$0.36
Beta
0.67
52W High
$100.00
52W Low
$50.23
50-Day MA
$88.12
200-Day MA
$78.16
Dividend Yield
—
Profit Margin
0.99%
Forward P/E
50.76
PEG Ratio
0.00

About Transcat Inc

Transcat, Inc. provides laboratory instrument and calibration services in the United States, Canada, and internationally. The company is headquartered in Rochester, New York.

Official WebsiteUSAFY End: March

Fundamentals

Revenue (TTM)$348.40M
Gross Profit (TTM)$113.22M
EBITDA$42.96M
Operating Margin5.47%
Return on Equity1.16%
Return on Assets2.18%
Revenue/Share (TTM)$37.29
Book Value$32.21
Price-to-Book2.76
Price-to-Sales (TTM)2.36
EV/Revenue2.788
EV/EBITDA25.03
Quarterly Earnings Growth (YoY)-60.00%
Quarterly Revenue Growth (YoY)21.60%
Shares Outstanding$9.36M
Float$9.13M
% Insiders2.45%
% Institutions105.52%

Historical Volatility

HV 10-Day
43.82%
HV 20-Day
37.68%
HV 30-Day
36.65%
HV 60-Day
41.18%
HV Rank
11.9%

Volatility is currently expanding

Analyst Ratings

Consensus ($104.33 target)
2
Buy
2
Hold

Latest News

Transcat Holdings: Recent Share Price Weakness Provides A Solid Entry Point

Transcat is rated BUY, leveraging a mission-critical, high-retention calibration services business with strong operating leverage and recurring revenue. TRNS delivered robust Q1 FY27 results: revenue rose 22% YoY, service segment operating income surged 35% YoY, and organic service growth was 13% YoY. The stock trades at a 50% discount to its recent EV/EBITDA peak, despite forward EBITDA growth 70% above the industrial sector median.

Seeking Alpha9/16/2026Positive
Transcat Q1 Earnings Call Highlights

Transcat NASDAQ: TRNS reported first-quarter fiscal 2027 revenue of $92.9 million, up 22% from a year earlier, as both its calibration services and distribution segments posted double-digit growth. The company said demand remained strong across its regulated end markets, including life sciences, aerospace and defense, and energy.

MarketBeat8/5/2026Positive
Transcat: Mission Critical Company With A Strong Moat

Transcat, Inc. is rated BUY, leveraging recurring revenue from government-mandated calibration services and a strong competitive moat. TRNS's growth is driven by high-margin services, strategic M&A, and recent expansion into Latin America, targeting life sciences and regulated industries. Despite a 58% YTD share price gain, TRNS trades at 18x forward EV/EBITDA, well below its historical peak valuation multiples.

Seeking Alpha6/25/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on TRNS and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More INDUSTRIALS Stocks

Data last updated: 9/28/2026